Wolfgang Miesbach on Differential Diagnosis of Thrombocytopenia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
”Today, our review article on the differential diagnosis of thrombocytopenia was published in the German Medical Journal – a comprehensive overview for clinical practice.
Why is this topic important?
Thrombocytopenia (platelet count < 150,000/µL) is a common coagulation disorder with significant clinical implications.
Approximately 90% of cases can be attributed to immune-mediated diseases, drug-induced forms, pregnancy-associated thrombocytopenia, or infections.
Most common causes:
- Pregnancy-associated thrombocytopenia
- Idiopathic thrombocytopenic purpura (ITP)
- Drug-induced forms (e.g., HIT with unfractionated heparin up to 1%)
- Infections and systemic diseases
Recognizing critical emergencies:
Life-threatening situations such as thrombotic thrombocytopenic purpura (TTP), heparin-induced thrombocytopenia (HIT), and disseminated intravascular coagulation (DIC) require immediate action.
Structured approach:
The publication offers a practice-oriented diagnostic algorithm that:
– Rules out pseudothrombocytopenia
– Identifies red flags
– Distinguishes between elective and emergency investigations
– Highlights specific treatment options
Take-home message:
Systematic differential diagnosis is crucial for initiating targeted therapies and preventing complications.
The paper offers practical guidance for both general practitioners and specialists.
The complete CME-certified publication is now available in Deutsches Ärzteblatt and offers 3 CME credits.
Many thanks and congratulations to the co-authors!”
Read the full article here.
Article: Differential diagnosis of thrombocytopenia
Authors: Miesbach Wolfgang, Stratmann Jan, Alesci Rosa Sonja, Chromik Jörg, Bakchoul Tamam, Wendt Ralph
Stay updated on all scientific advances in the field of platelet disorders with Hemostasis Today.
-
Mar 13, 2026, 17:21Emmanuel J Favaloro: Acquired Hemostasis Disorders Featured in New Issue of Seminars in Thrombosis and Hemostasis
-
Mar 13, 2026, 17:17Paolo Zamboni: New Insights from Australia on Jugular and Azygous Vein Chronic Obstruction
-
Mar 13, 2026, 17:06Srishti Goyal: Can Thalassemia Major Be Prevented?
-
Mar 13, 2026, 16:59Tagreed Alkaltham: Preventing the Risk of Transfusion Reactions Before They Occur
-
Mar 13, 2026, 16:52Giuseppe Lippi: New Insights Into Antiphospholipid Antibodies and Cardiovascular Thrombosis
-
Mar 13, 2026, 16:51Ahmet Dirican: Apixaban vs Rivaroxaban in Acute VTE
-
Mar 13, 2026, 16:47Sinju Thomas: Combined Red Cell and Plasma Exchange for Severe FES in Sickle Cell Disease
-
Mar 13, 2026, 16:44Michael Makris: Lower Bleeding Risk With Apixaban vs Rivaroxaban in Acute Venous Thrombosis
-
Mar 13, 2026, 16:36Muhammad Bilal: Principles and Clinical Uses of the Coombs Test